Lv41
440 积分 2025-01-13 加入
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment
2小时前
待确认
Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis
2小时前
已完结
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
2小时前
已完结
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
2小时前
已完结
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema
3小时前
已完结
Intravitreal Aflibercept for Diabetic Macular Edema
3小时前
已完结
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy
2天前
已完结
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
2天前
已完结
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
2天前
已完结
Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review
2天前
已完结
皖公网安备34019202002308
